MARLBOROUGH, Mass. (AP) — MARLBOROUGH, Mass. (AP) — Akoya Biosciences Inc. (AKYA) on Monday reported a loss of $8.2 million in its fourth quarter.
On a per-share basis, the Marlborough, Massachusetts-based company said it had a loss of 17 cents.
The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 15 cents per share.
The tissue analysis provider posted revenue of $21.3 million in the period, also falling short of Street forecasts. Three analysts surveyed by Zacks expected $21.6 million.
For the year, the company reported that its loss narrowed to $55.4 million, or $1.12 per share. Revenue was reported as $81.7 million.
In the final minutes of trading on Monday, the company’s shares hit $1.56. A year ago, they were trading at $4.91.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AKYA at https://www.zacks.com/ap/AKYA
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
